Appointments: Nordic Nanovector Loses CEO, Verona Pharma Loses CMO, Plus New CEOs At DalCor And PureTech Health
Executive Summary
This week's announcements include two CEO resignations at Nordic Nanovector and Verona Pharma, new CEOs at DalCor Pharmaceuticals and PureTech Health, new CMOs at Medigene, Argenx, Pneuma Respiratory and ReNeuron, plus board appointments.
You may also be interested in...
Nordic Nanovector Starting Pivotal Trial With Lead Asset Betalutin In R/R FL
Norwegian biotech is starting PARADIGME Phase IIb trial testing Betalutin in follicular lymphoma.
Pipeline Watch: Six New Approvals And 20 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Amicus Therapeutics, Perrigo and More
Recent executive moves in the industry include C-suite changes at Amicus Therapeutics and Assembly Biosciences. Meanwhile, new directors were appointed at Torrent Pharmaceuticals and Perrigo, among others.